KYMR
#967
Kymera Therapeutics, Inc. - Common Stock
111.1 9 USD
+0.01%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+0.72%
Changement Mensuel
+28.89%
Evolution sur 6 mois
+47.53%
Changement Annuel
+88.14%
Clôture Précédente
110.4 0
Open
111.5 0
Low
110.4 5
High
112.2 1
Volume
69
Financials
- Market Capitalization 9.15 B
- Employee 253
- Founded 2015
- CEO N/A
- Website www.kymeratx.com
- Headquarter Delaware, United States
- FIGI BBG00SDHC8D1
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-21.09
ratio cours/chiffre d'affaires
167.66
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 948 |  IONS Ionis Pharmaceuticals, Inc. - Common Stock | 55.23 USD | -2.68% | -33.99% | -24.85% | -23.42% | 9.13 B USD | ||
| 959 |  CORT Corcept Therapeutics Incorporated - Common Stock | 85.98 USD | +0.09% | -7.51% | +3.70% | +17.19% | 9.23 B USD | ||
| 968 |  HALO Halozyme Therapeutics, Inc. - Common Stock | 75.13 USD | -1.29% | -7.83% | +7.14% | +12.47% | 8.91 B USD | ||
| 983 |  CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 83.71 USD | +0.05% | +0.19% | +142.08% | +103.67% | 8.83 B USD |